Nir Sassi - Aug 4, 2021 Form 4 Insider Report for Indaptus Therapeutics, Inc. (INDP)

Role
Chief Financial Officer
Signature
/s/ Nir Sassi
Stock symbol
INDP
Transactions as of
Aug 4, 2021
Transactions value $
$0
Form type
4
Date filed
8/6/2021, 05:00 PM
Previous filing
Aug 2, 2021
Next filing
Feb 28, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INDP Stock Option (right to buy) Award $0 +35K $0.00 35K Aug 4, 2021 Common Stock 35K $8.87 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests and becomes exercisable over a period of twelve months in four equal quarterly installments and accelerate upon termination of Mr. Sassi's consulting agreement with Indaptus Therapeutics, Inc.